GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Biotoxtech Co Ltd (XKRX:086040) » Definitions » Cyclically Adjusted Revenue per Share

Biotoxtech Co (XKRX:086040) Cyclically Adjusted Revenue per Share : ₩2,006.59 (As of Dec. 2023)


View and export this data going back to 2007. Start your Free Trial

What is Biotoxtech Co Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Biotoxtech Co's adjusted revenue per share for the three months ended in Dec. 2023 was ₩534.037. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ₩2,006.59 for the trailing ten years ended in Dec. 2023.

During the past 12 months, Biotoxtech Co's average Cyclically Adjusted Revenue Growth Rate was 4.50% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 4.80% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 2.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Biotoxtech Co was 4.80% per year. The lowest was -0.80% per year. And the median was 2.70% per year.

As of today (2024-05-14), Biotoxtech Co's current stock price is ₩5510.00. Biotoxtech Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was ₩2,006.59. Biotoxtech Co's Cyclically Adjusted PS Ratio of today is 2.75.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Biotoxtech Co was 12.44. The lowest was 2.68. And the median was 4.50.


Biotoxtech Co Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Biotoxtech Co's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotoxtech Co Cyclically Adjusted Revenue per Share Chart

Biotoxtech Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,774.45 1,741.03 1,750.56 1,920.02 2,006.59

Biotoxtech Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,920.02 1,949.25 1,975.79 2,013.00 2,006.59

Competitive Comparison of Biotoxtech Co's Cyclically Adjusted Revenue per Share

For the Diagnostics & Research subindustry, Biotoxtech Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biotoxtech Co's Cyclically Adjusted PS Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Biotoxtech Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Biotoxtech Co's Cyclically Adjusted PS Ratio falls into.



Biotoxtech Co Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Biotoxtech Co's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=534.037/118.8477*118.8477
=534.037

Current CPI (Dec. 2023) = 118.8477.

Biotoxtech Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 298.015 99.253 356.850
201406 332.263 99.353 397.458
201409 365.630 99.608 436.253
201412 278.907 99.098 334.492
201503 230.474 99.720 274.682
201506 296.333 100.050 352.009
201509 312.622 100.110 371.136
201512 339.978 100.220 403.169
201603 309.193 100.560 365.422
201606 354.299 100.790 417.776
201609 402.730 101.460 471.748
201612 488.820 101.560 572.028
201703 378.029 102.850 436.829
201706 415.811 102.610 481.612
201709 422.675 103.490 485.399
201712 545.433 102.990 629.415
201803 484.230 104.100 552.830
201806 617.968 104.130 705.311
201809 533.055 105.650 599.644
201812 246.614 104.350 280.877
201903 437.605 104.490 497.735
201906 430.577 104.880 487.920
201909 408.009 105.200 460.940
201912 510.833 105.120 577.543
202003 414.910 105.540 467.227
202006 449.360 104.870 509.253
202009 424.968 106.200 475.579
202012 506.568 105.765 569.226
202103 484.463 107.357 536.315
202106 574.946 107.579 635.173
202109 601.447 108.759 657.237
202112 449.403 109.676 486.983
202203 556.493 111.806 591.543
202206 638.100 114.083 664.752
202209 655.765 114.831 678.701
202212 686.005 115.200 707.725
202303 547.556 116.550 558.353
202306 588.138 117.140 596.713
202309 448.996 119.111 448.003
202312 534.037 118.848 534.037

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Biotoxtech Co  (XKRX:086040) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Biotoxtech Co's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=5510.00/2006.59
=2.75

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Biotoxtech Co was 12.44. The lowest was 2.68. And the median was 4.50.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Biotoxtech Co Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Biotoxtech Co's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Biotoxtech Co (XKRX:086040) Business Description

Traded in Other Exchanges
N/A
Address
686-2 Yangcheong-Ri, Ochang-Eup, Cheongwon-Gun, Chungbuk, KOR, 353-883
Biotoxtech Co Ltd assesses safety for medical products, cosmetics, food, and chemical material. It also conducts validity tests and material screening and provides consulting services for non-clinical tests.

Biotoxtech Co (XKRX:086040) Headlines

No Headlines